Sunshine Biopharma, Inc. (SBFMW)Fort Lauderdale, United States | NasdaqCM
0.04 USD
|
Hot Take ↕ | Aug. 22, 2026, 5:17 a.m. EDT
The immediate outlook is severely bearish due to a catastrophic collapse in liquidity and trading activity. With volume dropping to just two shares and the price stuck at its 52-week low, there is no capital available to drive a recovery, rendering any technical bounce highly improbable. Fundamentally, the business is deteriorating rapidly with a 1.6% decline in revenue, negative operating cash flows, and a return on equity of nearly -22%. The company is burning cash without generating free cash flow, and the balance sheet shows significant leverage relative to equity. Furthermore, the complete absence of price history over multiple years and zero analyst recommendations suggests the market has effectively abandoned the security. There is no dividend to provide income, and the lack of recent news or catalysts leaves the stock in a state of stagnation rather than opportunity. |
| Attribute | Value |
|---|---|
| Debt to Equity Ratio | 2.463 |
| Revenue per Share | 49.666 |
| Beta | 1.31 |
| Profit Margins | -16.50% |
| Website | https://sunshinebiopharma.com |
| Attribute | Value |
|---|---|
| Address1 | 333 Las Olas Way |
| Address2 | CU4 Suite 433 |
| Ask | 0.0 |
| Ask Size | 0 |
| Beta | 1.31 |
| Bid | 0.0 |
| Bid Size | 0 |
| Book Value | 11.524 |
| City | Fort Lauderdale |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 0.0405 |
| Current Ratio | 5.457 |
| Custom Price Alert Confidence | HIGH |
| Day High | 0.0405 |
| Day Low | 0.031 |
| Debt To Equity | 2.463 |
| Display Name | Sunshine Biopharma |
| Ebitda | -4,848,974 |
| Ebitda Margins | -0.13718 |
| Eps Trailing Twelve Months | -2.214 |
| Esg Populated | 0 |
| Exchange | NCM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Two Week High | 0.0405 |
| Fifty Two Week High Change | 0.0 |
| Fifty Two Week High Change Percent | 0.0 |
| Fifty Two Week Low | 0.031 |
| Fifty Two Week Low Change | 0.009500001 |
| Fifty Two Week Low Change Percent | 0.30645165 |
| Fifty Two Week Range | 0.031 - 0.0405 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,784,295,000,000 |
| Float Shares | 3,808,824 |
| Free Cashflow | -2,011,131 |
| Full Exchange Name | NasdaqCM |
| Full Time Employees | 50 |
| Fullday Change | 0.0 |
| Fullday Change Percent | 0.0 |
| Fullday Price | 0.0405 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.303 |
| Gross Profits | 10,710,057 |
| Has Pre Post Market Data | 1 |
| Industry | |
| Industry Key | |
| Ipo Expected Date | 2,022-02-15 |
| Language | en-US |
| Long Business Summary | Sunshine Biopharma, Inc. operates as a pharmaceutical company that engages in the research and development of life-saving medicines in various therapeutic areas, including oncology and antivirals in the United States and Canada. The company is developing SBFM-PL4, a protease inhibitor for the treatment of SARS coronavirus infections; and K1.1 mRNA, a lipid nano-particle for liver cancer. It also offers Essential 9, an amino acids capsules; Calcium-Vitamin D supplement under the Essential Calcium-Vitamin D brand name; and L-Citrulline and Taurine products. In addition, the company provides various generic prescription drugs for osteoporosis, cardiovascular, antipsychotic, antibacterial, hypertension, anti-inflammatory, allergy, antibiotic, central nervous system, diabetes, urology, antifungal, antimalarial, oncology, gastroenterology, dermatology, smoking cessation, cholelithiasis, anticonvulsant, urology, women's health, acid reflux, and anticonvulsant indications. Sunshine The company is based in Fort Lauderdale, Florida. |
| Long Name | Sunshine Biopharma, Inc. |
| Market | us_market |
| Market State | CLOSED |
| Max Age | 86,400 |
| Message Board Id | finmb_78729055 |
| Net Income To Common | -5,832,664 |
| Open | 0.2428 |
| Operating Cashflow | -5,352,750 |
| Operating Margins | -0.17411 |
| Phone | 954 330 0684 |
| Previous Close | 0.0405 |
| Price Hint | 4 |
| Price To Book | 0.0035144046 |
| Profit Margins | -0.16500999 |
| Quick Ratio | 3.215 |
| Quote Source Name | Delayed Quote |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | 0.0 |
| Regular Market Change Percent | 0.0 |
| Regular Market Day High | 0.0405 |
| Regular Market Day Low | 0.031 |
| Regular Market Day Range | 0.031 - 0.0405 |
| Regular Market Open | 0.2428 |
| Regular Market Previous Close | 0.0405 |
| Regular Market Price | 0.0405 |
| Regular Market Time | 1,787,670,762 |
| Regular Market Volume | 26 |
| Return On Assets | -0.09906 |
| Return On Equity | -0.21917999 |
| Revenue Growth | -0.016 |
| Revenue Per Share | 49.666 |
| Sand P52 Week Change | 0.20504117 |
| Sector | |
| Sector Key | |
| Short Name | Sunshine Biopharma Inc. warrant |
| Source Interval | 15 |
| State | FL |
| Symbol | SBFMW |
| Total Cash | 14,029,781 |
| Total Cash Per Share | 3.618 |
| Total Debt | 678,338 |
| Total Revenue | 35,346,772 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -2.214 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Type Disp | Equity |
| Volume | 26 |
| Website | https://sunshinebiopharma.com |
| Zip | 33,301 |